Statements of Cash Flows (USD $)	12 Months Ended			98 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
Operating Activities:
Net loss	$ (30,130,951)	$ (28,769,417)	$ (105,742,615)	$ (241,906,285)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	6,225,854	6,166,123	7,541,962	30,739,001
Stock based compensation	621,505	924,315	1,572,607	13,433,197
Common stock issued for services	142,999	0	58,950	201,949
Realized loss on forward contracts	0	0	(63,915)	1,430,766
Foreign currency transaction loss (gain)	0	5,365	(145,940)	(590,433)
Amortization of financing costs and discounts	0	0	0	998,565
Impairment loss	822,350	3,401,610	78,000,000	83,993,440
Contract cancellation loss	0	576,812	590,774	1,167,586
Loss on extinguishment of liabilities	159,842	0	0	159,842
Accrued litigation settlement	1,700,000	0	0	1,700,000
Change in fair value of make-whole dividend liability	1,315,383	0	0	1,315,383
Changes in operating assets and liabilities:
Accounts receivable	(357,912)	241,923	142,939	(458,076)
Related party receivables and deposits	575,217	(596,339)	2,524	(21,122)
Inventories	271,941	309,570	(592,289)	(1,887,612)
Prepaid expenses and other current assets	(922,179)	151,319	123,724	(1,157,484)
Accounts payable	(412,619)	197,557	(435,089)	442,753
Related party payable	0	0	(53,808)	0
Accrued expenses	(370,766)	(281,906)	(691,346)	466,832
Deferred revenue	0	0	(250,705)	0
Warranty reserve	9,750	11,527	10,760	47,937
Net cash used in operating activities	(20,349,586)	(17,661,541)	(19,931,467)	(109,923,761)
Investing Activities:
Purchases of available-for-sale securities	0	(638,572)	(28,215,821)	(907,118,828)
Maturities and sales of available-for-sale securities	0	13,253,650	33,087,378	907,118,828
Purchase of property, plant and equipment	(519,741)	(6,267,207)	(9,681,565)	(135,341,744)
Restricted cash for manufacturing equipment	0	1,427,053	1,832,297	0
Patent activity costs	(413,876)	(211,996)	(60,408)	(937,947)
Net cash provided by (used in) investing activities	(933,617)	7,562,928	(3,038,119)	(136,279,691)
Financing Activities:
Proceeds from bridge loan financing	0	0	0	1,600,000
Repayment of bridge loan financing	0	0	0	(1,600,000)
Payment of debt financing costs	0	0	0	(273,565)
Payment of equity offering costs	(212,483)	0	0	(10,514,523)
Proceeds from debt	0	0	0	7,700,000
Repayment of debt	(264,936)	(648,059)	(582,257)	(2,449,866)
Proceeds from shareholder under Section 16(b)	0	0	0	148,109
Proceeds from issuance of stock and warrants	12,457,300	12,069,264	7,547,511	254,959,580
Redemption of Class A warrants	0	0	0	(48,128)
Net cash provided by financing activities	11,979,881	11,421,205	6,965,254	249,521,607
Net change in cash and cash equivalents	(9,303,322)	1,322,592	(16,004,332)	3,318,155
Cash and cash equivalents at beginning of period	12,621,477	11,298,885	27,303,217	0
Cash and cash equivalents at end of period	3,318,155	12,621,477	11,298,885	3,318,155
Supplemental Cash Flow Information:
Cash paid for interest	428,798	271,055	113,471	545,383
Cash paid for income taxes	0	0	0	0
Non-Cash Transactions:
ITN initial contribution of assets for equity	0	0	0	31,200
Note with ITN and related capital expenditures	0	0	0	1,100,000
Non-cash conversions	1,683,926	0	0	1,683,926
Make-whole provision on convertible preferred stock	3,514,699	0	0	1,830,773
Beneficial conversion feature on convertible preferred stock	$ 2,421,063	$ 0	$ 0	$ 2,421,063